Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/29/2025

Clinical Presentation and Recovery of Taste Loss After Viral Infection

Epidemiology and Symptoms

  • Loss of taste and smell occurs in 59-86% of COVID-19 patients, making it one of the hallmark symptoms 1, 2
  • Onset typically occurs 1-4 days after infection begins, and can present as the initial or isolated symptom in 11.9-22% of cases 1, 2
  • Recovery timeline shows 73% of patients improve within 7-14 days, though 20% have symptoms persisting beyond 14 days, and some experience permanent dysfunction 2
  • Objective testing reveals higher rates of dysfunction than self-reported: 98.3% had olfactory dysfunction by UPSIT testing even when only 35% reported taste/smell complaints 1

Clinical Distinctions

  • Traditional nasal symptoms (congestion, rhinorrhea) are often absent with COVID-19-related chemosensory dysfunction, unlike other viral upper respiratory infections 1
  • Isolated anosmia without other respiratory symptoms occurred in 3 of 35 patients in one study, highlighting that taste/smell loss can be the sole presenting feature 1

Etiology of Loss of Taste (Hypogeusia)

Viral Infections

  • Post-viral olfactory loss (PVOL) accounts for approximately 11% of community cases and 20-25% of specialist clinic presentations, with coronaviruses being a well-established cause, according to the Rhinology society 3, 4
  • Most taste loss in viral infections actually reflects loss of retronasal olfaction (flavor perception) rather than true taste dysfunction, as reported by the Rhinology society 3, 4

Loss of Smell in COVID-19 Patients

Clinical Presentation and Implications

  • Loss of taste usually reflects loss of retronasal olfaction (flavor perception) rather than true taste dysfunction, according to the Rhinology journal 5
  • The World Health Organization has added anosmia to its official symptom list, requiring self-isolation for affected individuals, as reported in Rhinology 5, 6
  • Healthcare workers and close-contact workers with anosmia pose transmission risk since viral load is comparable between symptomatic and minimally symptomatic individuals, as noted in Rhinology 5, 6, 7